ALEXION PHARMACEUTICALS, INC. Insider Trading for August 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for August 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 169.17 | 5,912 | 1,000,133 | 1,021,274 | 1 M to 1 M (-0.58 %) |
| Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 49.43 | 1,393 | 68,856 | 0 | |
| Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Option Exercise | M | 24.36 | 3,659 | 89,133 | 0 | |
| Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Sell | S | 170.53 | 5,052 | 861,518 | 12,786 | 17.8 K to 12.8 K (-28.32 %) |
| Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 49.43 | 1,393 | 68,856 | 17,838 | 16.4 K to 17.8 K (+8.47 %) |
| Aug 27 2014 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Buy | M | 24.36 | 3,659 | 89,133 | 16,445 | 12.8 K to 16.4 K (+28.62 %) |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 35,000 | 617,750 | 32,047 | |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 35,000 | 617,750 | 67,047 | |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 170.06 | 35,000 | 5,952,100 | 1,027,186 | 1.1 M to 1 M (-3.30 %) |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 35,000 | 617,750 | 1,062,186 | 1 M to 1.1 M (+3.41 %) |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 167.02 | 1,278 | 213,452 | 1,027,186 | 1 M to 1 M (-0.12 %) |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 166.40 | 15,570 | 2,590,848 | 1,028,464 | 1 M to 1 M (-1.49 %) |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.44 | 18,152 | 3,003,067 | 1,044,034 | 1.1 M to 1 M (-1.71 %) |
| Aug 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 35,000 | 617,750 | 1,062,186 | 1 M to 1.1 M (+3.41 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 24,542 | 433,166 | 102,047 | |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 80,458 | 1,420,084 | 126,589 | |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 163.74 | 6,711 | 1,098,859 | 1,027,186 | 1 M to 1 M (-0.65 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 162.88 | 6,008 | 978,583 | 1,033,897 | 1 M to 1 M (-0.58 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 161.91 | 8,076 | 1,307,585 | 1,039,905 | 1 M to 1 M (-0.77 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 161.08 | 3,747 | 603,567 | 1,047,981 | 1.1 M to 1 M (-0.36 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 24,542 | 433,166 | 1,051,728 | 1 M to 1.1 M (+2.39 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 160.61 | 27,633 | 4,438,136 | 1,027,186 | 1.1 M to 1 M (-2.62 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 159.92 | 52,825 | 8,447,774 | 1,054,819 | 1.1 M to 1.1 M (-4.77 %) |
| Aug 13 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 80,458 | 1,420,084 | 1,107,644 | 1 M to 1.1 M (+7.83 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 157.42 | 1,662 | 261,632 | 106,944 | 108.6 K to 106.9 K (-1.53 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 158.00 | 1,349 | 213,142 | 118,616 | 120 K to 118.6 K (-1.12 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 157.88 | 5,145 | 812,293 | 1,027,186 | 1 M to 1 M (-0.50 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 157.82 | 1,525 | 240,676 | 162,770 | 164.3 K to 162.8 K (-0.93 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Sell | S | 158.23 | 184 | 29,114 | 16,576 | 16.8 K to 16.6 K (-1.10 %) |